Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an…
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…
Clinical Complete Responses Observed in 4 out of 5 Patients in Subset of Patients with Low Grade Disease; Evidence of…
To aid in the early detection of breast cancer, Enable Me is offering Tampa Bay area mammography clinics free use…
Fully Leased Life Science Campus is Now Home to Leading Companies Including Pfizer and BD Biosciences SAN DIEGO, Oct. 17,…
DALLAS, Oct. 17, 2024 /PRNewswire/ -- Crosetto Foundation for the Reduction of Cancer Deaths welcomes Transparency in Science. Italian-American scientist…
Evvy Names Dr. Kate McLean, MD, MPH, FACOG as Chief Medical Officer, publishes peer-reviewed validation paper for its at-home vaginal…
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK…
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK…
PRINCETON, NJ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage…